GoodRx Announces Date for 2024 Investor Day
24 April 2024 - 10:00PM
Business Wire
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the
“Company”), the leading destination for prescription savings in the
U.S., today announced it will hold its first Investor Day on May
15, 2024, in New York City. The event will begin at 9:00 a.m.
Eastern Time (6:00 a.m. Pacific Time).
The event will feature presentations by GoodRx’s Interim CEO,
Scott Wagner; CFO, Karsten Voermann; as well as other leaders from
across the Company and will include an overview of the company’s
business drivers and its strategy for long-term growth, followed by
a Q&A session.
A link to access the live webcast, as well as any related
materials, will be available on GoodRx’s investor relations website
at https://investors.goodrx.com. Following the conclusion of the
event, a replay of the webcast will be available for at least 90
days.
About GoodRx
GoodRx is the leading destination for prescription savings in
the U.S. We offer consumers free access to transparent and lower
prices for generic and brand medications, as well as comprehensive
healthcare research and information. We also equip healthcare
professionals with efficient ways to find and prescribe affordable
medications. Since 2011, GoodRx has helped consumers save nearly
$70 billion and is one of the most downloaded medical apps over the
past decade.
GoodRx periodically posts information that may be important to
investors on its investor relations website at
https://investors.goodrx.com. We intend to use our website as a
means of disclosing material nonpublic information and for
complying with our disclosure obligations under Regulation FD.
Accordingly, investors and potential investors are encouraged to
consult GoodRx’s website regularly for important information, in
addition to following GoodRx’s press releases, filings with the
Securities and Exchange Commission and public conference calls and
webcasts. The information contained on, or that may be accessed
through, GoodRx’s website is not incorporated by reference into,
and is not a part of, this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240424260212/en/
Investor Contact GoodRx Whitney Notaro
wnotaro@goodrx.com
Press Contact GoodRx Lauren Casparis
lcasparis@goodrx.com
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
From Apr 2024 to May 2024
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
From May 2023 to May 2024